Expertise in
4
conditions

Andreas H. Diacon

Cape Town, Western Cape, 
Cape Town, WC, ZA 
Expertise in
4
conditions
Cape Town, Western Cape, 
Cape Town, WC, ZA 

Overview

Andreas Diacon practices practicing medicine in Cape Town, South Africa.

Mr. Diacon is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Pleurisy, Pleural Effusion, Scrofula, and Endoscopy.

He is actively involved in clinical research, co-authoring 198 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Cape Town, Western Cape, Cape Town, WC, South Africa
Other Locations
1 Smal Street, Bellville, WC 7530, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Open-label Trial Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Participants With Pulmonary Infection of Either XDR-TB or Treatment Intolerant / Non-responsive MDR-TB.
A Phase 3 Open-label Trial Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Participants With Pulmonary Infection of Either XDR-TB or Treatment Intolerant / Non-responsive MDR-TB.
Enrollment Status: Completed
Publish Date: September 08, 2025
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
Enrollment Status: Completed
Publish Date: March 07, 2024
Intervention Type: Drug
Study Drugs: Pretomanid, Bedaquiline, Moxifloxacin, Pyrazinamide, HRZE, HR
Study Phase: Phase 2/Phase 3
The Early Bactericidal Activity of High-Dose or Standard-Dose Isoniazid Among Adult Participants With Isoniazid-Resistant or Drug-Sensitive Tuberculosis
The Early Bactericidal Activity of High-Dose or Standard-Dose Isoniazid Among Adult Participants With Isoniazid-Resistant or Drug-Sensitive Tuberculosis
Enrollment Status: Completed
Publish Date: February 17, 2023
Intervention Type: Drug, Dietary supplement
Study Phase: Phase 2
A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.
A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.
Enrollment Status: Completed
Publish Date: January 11, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

198 Total Publications

Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026

Frequently Asked Questions about Andreas H. Diacon

Is Andreas H. Diacon a top-rated expert for Pulmonary Tuberculosis?

MediFind is an objective health platform that identifies experts based on real-world data. Andreas H. Diacon is classified as an Elite expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andreas H. Diacon participate in research or clinical trials?

Yes. Andreas H. Diacon has published 198 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Andreas H. Diacon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Diacon's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile